Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015752
Filing Date
2024-11-14
Accepted
2024-11-14 17:10:59
Documents
68
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240930x10q.htm   iXBRL 10-Q 1420312
2 EX-31.1 tmb-20240930xex31d1.htm EX-31.1 10562
3 EX-31.2 tmb-20240930xex31d2.htm EX-31.2 10412
4 EX-32.1 tmb-20240930xex32d1.htm EX-32.1 6630
5 EX-32.2 tmb-20240930xex32d2.htm EX-32.2 6323
  Complete submission text file 0001558370-24-015752.txt   6232439

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20240930.xsd EX-101.SCH 45645
7 EX-101.CAL tmb-20240930_cal.xml EX-101.CAL 40079
8 EX-101.DEF tmb-20240930_def.xml EX-101.DEF 187917
9 EX-101.LAB tmb-20240930_lab.xml EX-101.LAB 417776
10 EX-101.PRE tmb-20240930_pre.xml EX-101.PRE 317533
71 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240930x10q_htm.xml XML 955949
Mailing Address 12 PENNS TRAIL NEWTOWN PA 18940
Business Address 12 PENNS TRAIL NEWTOWN PA 18940 267-759-3680
Traws Pharma, Inc. (Filer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 241464204
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)